~~<i id='E3B1D1417E'><strike id='E3B1D1417E'><tt id='E3B1D1417E'><pre id='E3B1D1417E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：entertainment 2025-08-19 18:05:15 - browse：1

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

Editas Medicine, the winner of that battle in the U.S., will now cash in.

Vertex Pharmaceuticals and Editas announced Wednesday that Vertex will pay Editas $50 million, along with a series of annual payments through 2034, in exchange for rights to use CRISPR-Cas9 in Casgevy, the sickle cell therapy approved last week.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： 7 of the most gruesome medical devices in history

focus

explore

hotspot

explore

focus

hotspot

JustdaysaftertheendofRoev.Wade,CaitlinBernard,anOB-GYNinIndiana,toldtheIndianapolisStaraheartbreakin

WSS

CDC picks Alphabet's Verily for wasterwater surveillance contract

New rules on organ donation and transplantation 'will bring chaos'

2023 Nobel Prize in Medicine goes to Karikó and Weissman

The biotech scorecard for Q4: 16 stock

6 solutions to address cancer drug shortages and others

In new study, freeze

focus

entertainment

focus

The cancer drug shortage isn’t new — and neither are the solutions

As Taiwan prepares for anti

Heart attack and stroke risk calculators need revising

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Sports medicine is finally prioritizing gender equality

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Heart attack and stroke risk calculators need revising

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Hollywood unions extend contract negotiations for actors

Marvel Studios reveals new trailer for 'The Marvels': Watch here

explore

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Stop Congress from blocking public access to science

European officials brace for rough respiratory virus season

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Study points to new risk in gene therapy death of Terry Horgan

What to know about Saharan dust affecting the US and how it can affect health

hotspot

explore

focus

hotspot